Skip to main content

Echocardiographic Findings in HIV-Infected Patients

  • Chapter
Book cover Cardiovascular Disease in AIDS

Abstract

Echocardiography is an important imaging technique providing real-time imaging that can be performed at the bedside and easily repeated as needed (Table 1). Before the era of highly active anti-retroviral therapy (HAART), cardiac complications in HIV included pericardial effusion, dilated cardiomyopathy, myocarditis, endocarditis, pulmonary hypertension, cardiac neoplasm, coronary artery disease and drug-related cardiotoxicity [1, 2]. Cardiac abnormalities, although usually clinically silent, can be detected in necropsy series in the majority of infected HIV patients (40–60%) [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barbaro G (2002) Cardiovascular manifestations of HIV infection. Circulation 106:1420–5

    Article  PubMed  Google Scholar 

  2. Fisher SD, Lipshultz SE (2001) Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci 946:13–22

    Article  CAS  PubMed  Google Scholar 

  3. Barbaro G (2003) Evolution of the involvement of the cardiovascular system in HIV infection. Adv Cardiol 40:15–22

    Article  PubMed  Google Scholar 

  4. Barbarini G, Barbaro G (2003) Incidence of the involvement of the cardiovascular system in HIV infection. AIDS 17:S46–50

    Google Scholar 

  5. Reuter H, Burgess LJ, Doubell AF (2005) Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect 133:393–399

    Article  CAS  PubMed  Google Scholar 

  6. Heidenreich PA, Eisenberg MJ, Kee LL et al (1995) Pericardial effusion in AIDS: incidence and survival. Circulation 92:3229–3234

    CAS  PubMed  Google Scholar 

  7. Chen Y, Brennessel D, Walters J et al (1999) Immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 137:516–521

    Article  CAS  PubMed  Google Scholar 

  8. Pugliese A, Isnardi D, Saini A et al (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 40:282–284

    Article  CAS  PubMed  Google Scholar 

  9. Roy CL, Minor MA, Brookhart MA, Choudhry NK (2007) Does this patient with a pericardial effusion have cardiac tamponade? JAMA 297:1810–1818

    Article  CAS  PubMed  Google Scholar 

  10. Gowda RM, Khan IA, Sacchi TJ, Vasavada BC (2003) Cardiac tamponade in acquired immunodeficiency syndrome. Int J Cardiol 88:313–314

    Article  PubMed  Google Scholar 

  11. Iacobellis G, Pellicelli AM, Sharma AM et al (2007) Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol 99:1470–1472

    Article  PubMed  Google Scholar 

  12. Pinamonti B, Alberti E, Cigalotto A et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–289

    Article  CAS  PubMed  Google Scholar 

  13. Camerini F, Bussani R, Lenarda D et al (1991) Clinical aspects and haemodynamics in the followup of dilated cardiomyopathy and myocarditis. Eur Heart J 12(Suppl D):193–196

    PubMed  Google Scholar 

  14. Hiramitsu S, Morimoto S, Kato S et al (2001) Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. Jpn Circ 65:863–866

    Article  CAS  Google Scholar 

  15. Lieback E, Hardouin I, Meyer R et al (1996) Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J 17:135–142

    CAS  PubMed  Google Scholar 

  16. Felker GM, Boehmer JP, Hruban RH et al (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232

    Article  CAS  PubMed  Google Scholar 

  17. Mendes LA, Picard MH, Dec GW et al (1999) Ventricular remodeling in active myocarditis: myocarditis treatment trial. Am Heart J 138:303–308

    Article  CAS  PubMed  Google Scholar 

  18. Thuny F, Avierinos JF, Jop B et al (2006) Images in cardiovascular medicine: massive biventricular thrombosis as a consequence of myocarditis: findings from 2-dimensional and real-time 3-dimensional echocardiography. Circulation 113:e932–933

    Article  PubMed  Google Scholar 

  19. Mendes LA, Dec GW, Picard MH et al (1994) Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128:301–307

    Article  CAS  PubMed  Google Scholar 

  20. Swedberg K, Cleland J, Dargie H et al (2005) Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140

    Article  PubMed  CAS  Google Scholar 

  21. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIVpositive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 339:1093–1099

    Article  CAS  PubMed  Google Scholar 

  22. Cardoso JS, Moura B, Martins L et al (1998) Left ventricular dysfunction in human immunodeficiency virus (HIV) infected patients. Int J Cardiol 63:37–45

    Article  CAS  PubMed  Google Scholar 

  23. Longo-Mbenza B, Seghers KV, Phuati M et al (1998) Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol 64:63–73

    Article  CAS  PubMed  Google Scholar 

  24. Twagirumukiza M, Nkeramihigo E, Seminega B et al (2007) Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 5:129–137

    Article  CAS  PubMed  Google Scholar 

  25. Brown DL, Sather S, Cheitlin MD (1993) Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J 125:1439–1441

    Article  CAS  PubMed  Google Scholar 

  26. Galia N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243–2278

    Article  Google Scholar 

  27. Opravil M, Pechere M, Speich R et al (1997) HIV-associated primary pulmonary hypertension: a case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 155:990–995

    CAS  PubMed  Google Scholar 

  28. Mesa RA, Edell ES, Dunn WF, Edwards WD (1988) Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 73:37–45

    Article  Google Scholar 

  29. Petitpretz P, Brenot F, Azarian R et al (1994) Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation 89:2722–2727

    CAS  PubMed  Google Scholar 

  30. Ehrenreich H, Rieckmann P, Sinowatz F et al (1993) Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 150:4601–4609

    CAS  PubMed  Google Scholar 

  31. Humbert M, Monti G, Fartoukh M et al (1998) Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11:554–559

    CAS  PubMed  Google Scholar 

  32. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA (2000) HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 118:1133–1141

    Article  CAS  PubMed  Google Scholar 

  33. Zuber JP, Calmy A, Evison JM et al; Swiss HIV Cohort Study Group (2004) Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 38:1178–1185

    Article  PubMed  Google Scholar 

  34. Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification. J Am Soc Echocardiogr 18:1440–1463

    Article  PubMed  Google Scholar 

  35. Martinez-Garcia T, Sobrino JM, Pujol E et al (2000) Ventricular mass and diastolic function in patients infected by the humanimmuno deficiency virus. Heart 84:620–624

    Article  CAS  PubMed  Google Scholar 

  36. Coudray N, de Zuttere D, Force G et al (1995) Ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 16:61–67

    CAS  PubMed  Google Scholar 

  37. Samaan SA, Foster A, Raizada V et al (1995) Myocardial atrophy in acquired immunodeficiency syndrome: associated wasting. Am Heart J 130:823–827

    Article  CAS  PubMed  Google Scholar 

  38. Meng Q, Lima JA, Lai H, Vlahov D et al (2002) HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 30:306–310

    CAS  PubMed  Google Scholar 

  39. Losa JE, Miro JM, Del Rio A et al (2003) Endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect 9:45–54

    Article  CAS  PubMed  Google Scholar 

  40. De Rosa FG, Cicalini S, Canta F et al (2007) Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIVinfected patients. Infection 35:154–160

    Article  PubMed  Google Scholar 

  41. Gebo KA, Burkey MD, Lucas GM et al (2006) Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43:426–432

    Article  PubMed  Google Scholar 

  42. Valencia E, Miro J (2004) Endocarditis in the setting of HIV infection. AIDS Rev 6:97–106

    PubMed  Google Scholar 

  43. Horstkotte D, Follath F, Gutschik E et al (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25:267–276

    Article  PubMed  Google Scholar 

  44. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99:962–972

    Article  PubMed  Google Scholar 

  45. Khan NU, Ahmed S, Wagner P et al (2004) Cardiac involvement in non-Hodgkin’s lymphoma: with and without HIV infection. Int J Cardiovasc Imaging 20:477–481

    Article  PubMed  Google Scholar 

  46. Iwahashi N, Nakatani S, Kakuchi H et al (2005) Cardiac tumor as an initial manifestation of acquired immunodeficiency syndrome. Circ J 69:243–245

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Italia

About this chapter

Cite this chapter

Ederhy, S., Meuleman, C., Haddour, N., Dufaitre, G., Boccara, F., Cohen, A. (2009). Echocardiographic Findings in HIV-Infected Patients. In: Barbaro, G., Boccara, F. (eds) Cardiovascular Disease in AIDS. Springer, Milano. https://doi.org/10.1007/978-88-470-0761-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0761-1_6

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0760-4

  • Online ISBN: 978-88-470-0761-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics